Susquehanna International Group, LLP Stoke Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 187,908 shares of STOK stock, worth $1.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

187,908

Previous 134,141 40.08%

Holding current value

$1.67 Million

Previous $1.65 Million 25.73%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$10.8 - $13.92 $580,683 - $748,436	53,767 Added 40.08%	187,908 $2.07 Million
Q3 2024 Nov 14, 2024	BUY	$12.24 - $15.92 $1.52 Million - $1.97 Million	123,914 Added 1211.64%	134,141 $1.65 Million
Q2 2024 Aug 15, 2024	SELL	$11.03 - $17.52 $764,367 - $1.21 Million	-69,299 Reduced 87.14%	10,227 $138,000
Q1 2024 May 07, 2024	BUY	$4.12 - $14.17 $239,957 - $825,289	58,242 Added 273.64%	79,526 $1.07 Million
Q4 2023 Feb 14, 2024	SELL	$3.37 - $5.4 $171,725 - $275,167	-50,957 Reduced 70.54%	21,284 $111,000
Q3 2023 Nov 14, 2023	BUY	$3.78 - $11.99 $169,170 - $536,600	44,754 Added 162.82%	72,241 $284,000
Q2 2023 Aug 11, 2023	BUY	$7.93 - $13.82 $94,882 - $165,356	11,965 Added 77.08%	27,487 $292,000
Q1 2023 May 16, 2023	BUY	$7.65 - $10.38 $118,743 - $161,118	15,522 New	15,522 $129,000
Q2 2022 Aug 15, 2022	SELL	$10.36 - $23.93 $149,277 - $344,807	-14,409 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$17.19 - $26.1 $235,176 - $357,074	-13,681 Reduced 48.7%	14,409 $303,000
Q4 2021 Feb 14, 2022	BUY	$18.11 - $30.72 $127,530 - $216,330	7,042 Added 33.46%	28,090 $674,000
Q3 2021 Nov 15, 2021	BUY	$23.65 - $34.44 $227,181 - $330,830	9,606 Added 83.95%	21,048 $535,000
Q2 2021 Aug 11, 2021	SELL	$30.53 - $41.09 $556,592 - $749,111	-18,231 Reduced 61.44%	11,442 $385,000
Q1 2021 May 17, 2021	BUY	$36.08 - $69.81 $821,974 - $1.59 Million	22,782 Added 330.61%	29,673 $1.15 Million
Q4 2020 Feb 16, 2021	SELL	$33.62 - $61.93 $130,311 - $240,040	-3,876 Reduced 36.0%	6,891 $427,000
Q3 2020 Nov 16, 2020	SELL	$22.23 - $37.48 $46,549 - $78,483	-2,094 Reduced 16.28%	10,767 $361,000
Q1 2020 May 15, 2020	BUY	$16.8 - $34.15 $216,064 - $439,203	12,861 New	12,861 $295,000

Others Institutions Holding STOK

# of Institutions

136

Shares Held

57.3M

Call Options Held

5.7K

Put Options Held

24.4K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $350M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Stoke Therapeutics, Inc. Transaction History